Work

Supplementary table S3 from A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table S3. All observed coding mutations with detailed annotations
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4362396740
Cites:
Cited by:
Related to: 10